X3 (XTKG) Competitors

$0.59 0.00 (0.00%)

As of 05/15/2026

XTKG vs. GIBO, HCTI, AMST, MNDR, and BNZI

Should you buy X3 stock or one of its competitors? MarketBeat compares X3 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with X3 include GIBO (GIBO), Healthcare Triangle (HCTI), Amesite (AMST), Mobile-health Network Solutions (MNDR), and Banzai International (BNZI). These companies are all part of the "computer software" industry.

How does X3 compare to GIBO?

X3 (NASDAQ:XTKG) and GIBO (NASDAQ:GIBO) are both small-cap computer software companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
X3	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
GIBO	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
X3	N/A	N/A	N/A
GIBO	N/A	N/A	N/A

X3 has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, GIBO has a beta of -1.81, indicating that its share price is 281% less volatile than the broader market.

GIBO has higher revenue and earnings than X3.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
X3	$6.29M	0.20	-$26.20M	N/A	N/A
GIBO	$30M	0.16	-$24.85M	N/A	N/A

In the previous week, GIBO had 5 more articles in the media than X3. MarketBeat recorded 5 mentions for GIBO and 0 mentions for X3. GIBO's average media sentiment score of 0.81 beat X3's score of 0.00 indicating that GIBO is being referred to more favorably in the news media.

Company	Overall Sentiment
X3	Neutral
GIBO	Positive

1.9% of X3 shares are held by institutional investors. Comparatively, 66.3% of GIBO shares are held by institutional investors. 23.9% of X3 shares are held by company insiders. Comparatively, 0.3% of GIBO shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

GIBO beats X3 on 5 of the 9 factors compared between the two stocks.

How does X3 compare to Healthcare Triangle?

X3 (NASDAQ:XTKG) and Healthcare Triangle (NASDAQ:HCTI) are both small-cap computer software companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

1.9% of X3 shares are owned by institutional investors. Comparatively, 0.3% of Healthcare Triangle shares are owned by institutional investors. 23.9% of X3 shares are owned by company insiders. Comparatively, 0.1% of Healthcare Triangle shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

X3 has a net margin of 0.00% compared to Healthcare Triangle's net margin of -70.43%. X3's return on equity of 0.00% beat Healthcare Triangle's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
X3	N/A	N/A	N/A
Healthcare Triangle	-70.43%	-644.17%	-82.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
X3	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Healthcare Triangle	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

X3 has a beta of 1.6, indicating that its stock price is 60% more volatile than the broader market. Comparatively, Healthcare Triangle has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Healthcare Triangle has higher revenue and earnings than X3.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
X3	$6.29M	0.20	-$26.20M	N/A	N/A
Healthcare Triangle	$13.89M	0.31	-$9.48M	-$2.60 thousand	N/A

In the previous week, Healthcare Triangle had 6 more articles in the media than X3. MarketBeat recorded 6 mentions for Healthcare Triangle and 0 mentions for X3. Healthcare Triangle's average media sentiment score of 0.62 beat X3's score of 0.00 indicating that Healthcare Triangle is being referred to more favorably in the news media.

Company	Overall Sentiment
X3	Neutral
Healthcare Triangle	Positive

Summary

X3 beats Healthcare Triangle on 6 of the 11 factors compared between the two stocks.

How does X3 compare to Amesite?

X3 (NASDAQ:XTKG) and Amesite (NASDAQ:AMST) are both small-cap computer software companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

X3 has a beta of 1.6, indicating that its stock price is 60% more volatile than the broader market. Comparatively, Amesite has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

1.9% of X3 shares are owned by institutional investors. Comparatively, 3.6% of Amesite shares are owned by institutional investors. 23.9% of X3 shares are owned by company insiders. Comparatively, 36.0% of Amesite shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

X3 has a net margin of 0.00% compared to Amesite's net margin of -1,024.91%. X3's return on equity of 0.00% beat Amesite's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
X3	N/A	N/A	N/A
Amesite	-1,024.91%	-118.33%	-103.03%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
X3	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Amesite	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Amesite has lower revenue, but higher earnings than X3.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
X3	$6.29M	0.20	-$26.20M	N/A	N/A
Amesite	$110K	34.23	-$3.62M	-$0.64	N/A

In the previous week, Amesite had 4 more articles in the media than X3. MarketBeat recorded 4 mentions for Amesite and 0 mentions for X3. Amesite's average media sentiment score of 0.04 beat X3's score of 0.00 indicating that Amesite is being referred to more favorably in the news media.

Company	Overall Sentiment
X3	Neutral
Amesite	Neutral

Summary

Amesite beats X3 on 6 of the 11 factors compared between the two stocks.

How does X3 compare to Mobile-health Network Solutions?

X3 (NASDAQ:XTKG) and Mobile-health Network Solutions (NASDAQ:MNDR) are both small-cap computer software companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

X3 has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, Mobile-health Network Solutions has a beta of -1.3, indicating that its share price is 230% less volatile than the broader market.

1.9% of X3 shares are owned by institutional investors. 23.9% of X3 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
X3	N/A	N/A	N/A
Mobile-health Network Solutions	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
X3	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mobile-health Network Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Mobile-health Network Solutions has higher revenue and earnings than X3.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
X3	$6.29M	0.20	-$26.20M	N/A	N/A
Mobile-health Network Solutions	$7.65M	0.66	-$3.38M	N/A	N/A

In the previous week, Mobile-health Network Solutions had 3 more articles in the media than X3. MarketBeat recorded 3 mentions for Mobile-health Network Solutions and 0 mentions for X3. Mobile-health Network Solutions' average media sentiment score of 0.48 beat X3's score of 0.00 indicating that Mobile-health Network Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
X3	Neutral
Mobile-health Network Solutions	Neutral

Summary

Mobile-health Network Solutions beats X3 on 5 of the 8 factors compared between the two stocks.

How does X3 compare to Banzai International?

Banzai International (NASDAQ:BNZI) and X3 (NASDAQ:XTKG) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Banzai International has higher revenue and earnings than X3.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Banzai International	$12.16M	0.74	-$22.49M	-$131.00	N/A
X3	$6.29M	0.20	-$26.20M	N/A	N/A

X3 has a net margin of 0.00% compared to Banzai International's net margin of -184.96%. X3's return on equity of 0.00% beat Banzai International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Banzai International	-184.96%	-429.90%	-63.36%
X3	N/A	N/A	N/A

Banzai International has a beta of -0.95, indicating that its share price is 195% less volatile than the broader market. Comparatively, X3 has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market.

In the previous week, Banzai International had 10 more articles in the media than X3. MarketBeat recorded 10 mentions for Banzai International and 0 mentions for X3. Banzai International's average media sentiment score of 0.43 beat X3's score of 0.00 indicating that Banzai International is being referred to more favorably in the media.

Company	Overall Sentiment
Banzai International	Neutral
X3	Neutral

Banzai International currently has a consensus target price of $480.00, suggesting a potential upside of 6,166.32%. Given Banzai International's stronger consensus rating and higher probable upside, equities analysts plainly believe Banzai International is more favorable than X3.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Banzai International	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
X3	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

96.8% of Banzai International shares are held by institutional investors. Comparatively, 1.9% of X3 shares are held by institutional investors. 2.8% of Banzai International shares are held by insiders. Comparatively, 23.9% of X3 shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Banzai International beats X3 on 9 of the 14 factors compared between the two stocks.

Get X3 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XTKG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XTKG vs. The Competition

Export

Metric	X3	ADVERTISING/MKTG SVCS Industry	Business Sector	NASDAQ Exchange
Market Cap	$1.23M	$1.97B	$6.41B	$12.48B
Dividend Yield	N/A	4.36%	3.18%	5.25%
P/E Ratio	N/A	26.38	31.07	25.24
Price / Sales	0.20	119.38	417.72	82.47
Price / Cash	N/A	10.60	23.29	56.04
Price / Book	0.00	17.46	6.75	6.90
Net Income	-$26.20M	$17.81M	$203.22M	$334.66M
7 Day Performance	N/A	-4.39%	1.85%	0.13%
1 Month Performance	N/A	2.92%	-2.97%	1.11%
1 Year Performance	-99.75%	335.62%	31.15%	30.62%

X3 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XTKG X3	0.0925 of 5 stars	$0.59 flat	N/A	N/A	$1.23M	$6.29M	N/A	200	High Trading Volume
GIBO GIBO	1.457 of 5 stars	$1.31 -0.8%	N/A	N/A	$4.79M	$30M	N/A	N/A	News Coverage Earnings Report
HCTI Healthcare Triangle	1.0472 of 5 stars	$2.32 -2.5%	N/A	-99.6%	$4.68M	$13.89M	N/A	80	News Coverage Upcoming Earnings Analyst Revision
AMST Amesite	0.3475 of 5 stars	$0.91 -5.8%	N/A	-63.2%	$4.42M	$110K	N/A	20	Short Interest Increase
MNDR Mobile-health Network Solutions	0.525 of 5 stars	$1.17 -4.9%	N/A	-84.9%	$4.28M	$7.65M	N/A	N/A	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XTKG) was last updated on 5/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

X3 (XTKG) Competitors

XTKG vs. GIBO, HCTI, AMST, MNDR, and BNZI

How does X3 compare to GIBO?

Summary

How does X3 compare to Healthcare Triangle?

Summary

How does X3 compare to Amesite?

Summary

How does X3 compare to Mobile-health Network Solutions?

Summary

How does X3 compare to Banzai International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XTKG vs. The Competition

X3 Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

X3 (XTKG) Competitors

XTKG vs. GIBO, HCTI, AMST, MNDR, and BNZI

How does X3 compare to GIBO?

Do analysts prefer XTKG or GIBO?

Is XTKG or GIBO more profitable?

Which has more risk & volatility, XTKG or GIBO?

Which has stronger valuation and earnings, XTKG or GIBO?

Does the media refer more to XTKG or GIBO?

Do insiders & institutionals have more ownership in XTKG or GIBO?

Summary

How does X3 compare to Healthcare Triangle?

Do institutionals & insiders have more ownership in XTKG or HCTI?

Is XTKG or HCTI more profitable?

Do analysts prefer XTKG or HCTI?

Which has more risk and volatility, XTKG or HCTI?

Which has higher valuation & earnings, XTKG or HCTI?

Does the media prefer XTKG or HCTI?

Summary

How does X3 compare to Amesite?

Which has more risk and volatility, XTKG or AMST?

Do institutionals & insiders have more ownership in XTKG or AMST?

Is XTKG or AMST more profitable?

Do analysts prefer XTKG or AMST?

Which has higher valuation & earnings, XTKG or AMST?

Does the media prefer XTKG or AMST?

Summary

How does X3 compare to Mobile-health Network Solutions?

Which has more volatility & risk, XTKG or MNDR?

Do insiders and institutionals have more ownership in XTKG or MNDR?

Is XTKG or MNDR more profitable?

Do analysts rate XTKG or MNDR?

Which has better valuation and earnings, XTKG or MNDR?

Does the media prefer XTKG or MNDR?

Summary

How does X3 compare to Banzai International?

Which has stronger earnings & valuation, BNZI or XTKG?

Is BNZI or XTKG more profitable?

Which has more risk and volatility, BNZI or XTKG?

Does the media favor BNZI or XTKG?

Do analysts prefer BNZI or XTKG?

Do institutionals and insiders hold more shares of BNZI or XTKG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XTKG vs. The Competition

X3 Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools